Research

A double-blind, randomized, parallel group, placebo controlled, sequential...

Pagina-navigatie:

Title	A double-blind, randomized, parallel group, placebo controlled, sequential dose escalation study of anti-MCP-1 therapy in patients with rheumatoid arthritis
Period	01 / 2003 - unknown
Status	Current
Data Supplier:	Aangemeld door projectleider

Related organisations

Secretariat	Department of Internal Medicine (UvA)

Project leader	Prof.dr. P.P. Tak

A34800	Drugs and pesticides
A73200	Second-line health care
D23210	Dermatology, venereology, rheumatology, orthopedics
D23340	Biopharmacology, toxicology

Update this data